Myriad Genetics MYGN Payments To Acquire Other Productive Assets
Payments To Acquire Other Productive Assets at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireOtherProductiveAssets.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's payments to acquire other productive assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's payments to acquire other productive assets?
- Myriad Genetics (MYGN) reported payments to acquire other productive assets of $5.4M in Q1 2026.
- How has Myriad Genetics's payments to acquire other productive assets changed year-over-year?
- Myriad Genetics's payments to acquire other productive assets increased by 1.9% year-over-year, from $5.3M to $5.4M.
- What is the long-term trend for Myriad Genetics's payments to acquire other productive assets?
- Over 3 years (2021 to 2025), Myriad Genetics's payments to acquire other productive assets has grown at a -4.7% compound annual growth rate (CAGR), from $18M to $15.6M.
- What does payments to acquire other productive assets mean?
- Captures cash outflows dedicated to purchasing long-term assets, such as laboratory equipment, machinery, or specialized technology, necessary for ongoing operations. This metric reflects the company's commitment to maintaining and expanding its productive capacity. High levels of investment indicate a focus on growth and operational modernization.